Q32 Bio
QTTB
87 hedge funds and large institutions have $49.9M invested in Q32 Bio in 2022 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 20 increasing their positions, 28 reducing their positions, and 34 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.4% less ownership
Funds ownership: 2.85% → 2.45% (-0.4%)
18% less funds holding
Funds holding: 106 → 87 (-19)
29% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 28
44% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 34
44% less capital invested
Capital invested by funds: $89.6M → $49.9M (-$39.7M)
97% less call options, than puts
Call options by funds: $36K | Put options by funds: $1.1M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$1.37M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$1.17M |
| 3 |
OMC
Oasis Management Company
Grand Cayman,
Cayman Islands
|
+$531K |
| 4 |
Citigroup
New York
|
+$410K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$374K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$4.2M |
| 2 |
State Street
Boston,
Massachusetts
|
-$1.62M |
| 3 |
VC
Vivo Capital
Palo Alto,
California
|
-$916K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$817K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$746K |
QTTB Hedge Fund Activity: Q2 2022 in Review
87 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Q32 Bio (QTTB) for Q2 2022, worth a combined $49.9M — down 44% from $89.6M a quarter earlier.
Sellers outnumbered buyers: 34 funds closed out of QTTB and 19 opened new positions — a net loss of 15 holders — while 28 trimmed existing stakes and 20 added.
The largest buyer was Millennium Management, opening a new position worth an estimated $1.37M. The largest seller was BlackRock, cutting an estimated $4.2M.
- 87 institutional investors held Q32 Bio (QTTB) as of Q2 2022, down from 106 in Q1 2022.
- Funds reported $49.9M of Q32 Bio stock for Q2 2022, down 44% quarter-over-quarter.
- 19 funds opened new Q32 Bio positions in Q2 2022 and 34 closed out, a net change of -15 holders.
- The largest Q32 Bio buyer in Q2 2022 was Millennium Management, an estimated $1.37M added.
- The largest Q32 Bio seller in Q2 2022 was BlackRock, an estimated $4.2M sold.
Based on aggregated 13F filings for Q2 2022.